Sartorius Stedim Biotech S.A.
Sartorius Stedim Biotech S.A. (SDMHF) Revenue
Annual & quarterly revenue history · segment & region breakdown
SDMHF · revenue · updated Jun 8, 2026
Core revenue metrics
Trailing 12 monthsSartorius Stedim Biotech S.A. trailing twelve-month (TTM) revenue is $2.99B, an increase of 6.70% year-over-year from $2.97B in FY2025.
Revenue trend
2025 – 2006 · AnnualRevenue history
| Fiscal year end | Revenue | Change | Growth |
|---|---|---|---|
| 2025-12-31 | $2.97B | +$0.19B | +6.70% |
| 2024-12-31 | $2.78B | +$0.00B | +0.16% |
| 2023-12-31 | $2.78B | -$0.72B | -20.53% |
| 2022-12-31 | $3.49B | +$0.61B | +20.98% |
| 2021-12-31 | $2.89B | +$0.98B | +51.14% |
| 2020-12-31 | $1.91B | +$0.47B | +32.59% |
| 2019-12-31 | $1.44B | +$0.23B | +18.84% |
| 2018-12-31 | $1.21B | +$0.13B | +12.13% |
| 2017-12-31 | $1.08B | +$0.03B | +2.80% |
| 2016-12-31 | $1.05B | +$0.17B | +18.92% |
Compare revenue vs peers
Medical - Instruments & SuppliesCompare SDMHF revenue against listed peers. Click any row to open that company's revenue tab.
About Revenue & Reporting
Revenue (also called sales, net sales, or turnover) is the total income Sartorius Stedim Biotech S.A. receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.
Sartorius Stedim Biotech S.A. reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in EUR.
Data sourced from Sartorius Stedim Biotech S.A.'s 10-K and 10-Q SEC filings via Financial Modeling Prep.
Frequently asked questions
SDMHF revenue · 4 questionsSDMHF's trailing twelve-month (TTM) revenue is $2.99B. That is an increase of 6.70% year-over-year from $2.97B in FY2025.
▸ Source: FMP · Sartorius Stedim Biotech S.A. SEC filings · GAAP · Sartorius Stedim Biotech S.A. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026